Hana Pharm Co., Ltd.
EK-Tower
10th Floor 407 Teheran-ro Gangnam-gu
Seoul
South Korea
82 2 577 7667
https://www.hanaph.co.kr
版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工:
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Taehong Choi | Pres, CEO & Director | 無 | 無 | 無 |
| Hong-Joo Yun | Director of Bus. Department, CFO & Director | 無 | 無 | 無 |
| Elia Cho | Director of Global Department & Director | 無 | 無 | 無 |
截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 KRW。
描述
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.
公司管治
截至 無 止，Hana Pharm Co., Ltd. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
